In agreement with this finding, a pancancer analysis confirmed the high expression of CD155 in ESCA, as well as in other cancers, including cholangiocarcinoma, colon adenocarcinoma, and pancreatic adenocarcinoma (Figure 1C) (Supplementary Figure S2). The gene discussed is PVR; the disease is pancreatic adenocarcinoma.